Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 220 for Multiple Myeloma

Edit search filters
  1. Solitary Bone Plasmacytomas to Elucidate Their Pathogenesis and Risk of Progression to Multiple Myeloma

    Rochester, MN

  2. A Study of the Gut Microbiome in Patients with Lymphoma or Myeloma, and Undergoing Stem Cell Transplant

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study to Explore Quality of Life According to Treatment Plan for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant

    Rochester, MN

  4. American Society of Hematology Research Collaborative’s Data Hub Multiple Myeloma Program

    Rochester, MN

  5. Sarcopenia Impact Among Older Patients With Newly Diagnosed Multiple Myeloma

    Rochester, MN

  6. Perceived Financial Hardship in Patients with Multiple Myeloma and Their Caregivers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. American Society of Hematology Research Collaborative’s Data Hub Multiple Myeloma Program

    Rochester, MN

  8. MMRF Molecular Profiling Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. The Impact of a Geriatric Assessment in Elderly Patients with Multiple Myeloma

    Rochester, MN

  10. Longterm Follow-up of Subjects Treated With bb2121

    Rochester, MN

.

Mayo Clinic Footer